Raymond James Financial Services Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,500	Closed	-$180K	–	2561
2016 Q4	$180K	Sell	14,500 -251	-2%	-$3.02K	﹤0.01%	2097
2016 Q3	$202K	Sell	14,751 -13,585	-48%	-$136K	﹤0.01%	2036
2016 Q2	$209K	Sell	28,336 -141	-0.5%	-$1.06K	﹤0.01%	1952
2016 Q1	$182K	Buy	+28,477	New	+$160K	﹤0.01%	1794

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Raymond James Financial Services Advisors's ARIA Position: Q1 2017 in Review

Raymond James Financial Services Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 14,500 shares — an estimated $180K sold.

Raymond James Financial Services Advisors first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $209K in Q2 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Raymond James Financial Services Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Raymond James Financial Services Advisors sold 14,500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $180K.
Raymond James Financial Services Advisors first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
Raymond James Financial Services Advisors's Ariad Pharmaceuticals Inc position peaked at $209K in Q2 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2017, filed 9 May 2017.